The clinical outcomes of reclassified erythroleukemia (erythroid/myeloid) as myelodysplastic syndrome (MDS) per 2017 WHO guideline compared to MDS

Am J Hematol. 2018 Nov;93(11):E355-E357. doi: 10.1002/ajh.25239. Epub 2018 Oct 2.
No abstract available

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Female
  • Humans
  • Leukemia, Erythroblastic, Acute / classification*
  • Leukemia, Erythroblastic, Acute / mortality
  • Male
  • Myelodysplastic Syndromes / classification*
  • Myelodysplastic Syndromes / mortality
  • Practice Guidelines as Topic
  • Retrospective Studies
  • Survival Analysis
  • Treatment Outcome
  • World Health Organization